药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Chloroprocaine
Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen
The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Temsirolimus.
Chloroprocaine
Rabies virus inactivated antigen, A
The therapeutic efficacy of Rabies virus inactivated antigen, A can be decreased when used in combination with Temsirolimus.
Chloroprocaine
Rotavirus vaccine
The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Temsirolimus.
Chloroprocaine
Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen
The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Temsirolimus.
Chloroprocaine
Rabies virus inactivated antigen, B
The therapeutic efficacy of Rabies virus inactivated antigen, B can be decreased when used in combination with Temsirolimus.
Chloroprocaine
Anthrax immune globulin human
The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Temsirolimus.
Chloroprocaine
TG4010
The therapeutic efficacy of TG4010 can be decreased when used in combination with Temsirolimus.
Chloroprocaine
Vitespen
The therapeutic efficacy of Vitespen can be decreased when used in combination with Temsirolimus.
Chloroprocaine
GI-5005
The therapeutic efficacy of GI-5005 can be decreased when used in combination with Temsirolimus.
Chloroprocaine
SRP 299
The therapeutic efficacy of SRP 299 can be decreased when used in combination with Temsirolimus.
Chloroprocaine
Rindopepimut
The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Temsirolimus.
Chloroprocaine
INGN 225
The therapeutic efficacy of INGN 225 can be decreased when used in combination with Temsirolimus.
Chloroprocaine
PEV3A
The therapeutic efficacy of PEV3A can be decreased when used in combination with Temsirolimus.
Chloroprocaine
G17DT
The therapeutic efficacy of G17DT can be decreased when used in combination with Temsirolimus.
Chloroprocaine
Pergolide
The serum concentration of Pergolide can be increased when it is combined with Temsirolimus.
Chloroprocaine
Terguride
The serum concentration of Terguride can be increased when it is combined with Temsirolimus.
Chloroprocaine
Lysergic acid diethylamide
The serum concentration of Lysergic acid diethylamide can be increased when it is combined with Temsirolimus.
Chloroprocaine
Dihydroergocryptine
The serum concentration of Temsirolimus can be increased when it is combined with Dihydroergocryptine.
Chloroprocaine
Dihydroergocristine
The serum concentration of Temsirolimus can be increased when it is combined with Dihydroergocristine.
Chloroprocaine
Dihydroergocornine
The serum concentration of Temsirolimus can be increased when it is combined with Dihydroergocornine.